{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:38:56Z","timestamp":1792733936988,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The role of\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      in the pathophysiology of irritable bowel syndrome (IBS) remains controversial, with emerging evidence suggesting subtype-specific differences in pathogenicity. Interleukin-8 (IL-8), a key pro-inflammatory chemokine, has been implicated in mucosal immune activation in both IBS and parasitic infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to investigate the association between\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      subtypes and clinical manifestations of IBS, with a particular focus IL-8 as part of the systemic pro-inflammatory immune response associated with functional GIT disorders and intestinal infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this cross-sectional study, 298 symptomatic patients attending a tertiary gastroenterology clinic were evaluated using Rome IV criteria for IBS diagnosis. Identification of\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      in stool samples was done by direct microscopic examination. Subtype identification using PCR and subtype-specific sequence-tagged site primers were also performed. A balanced random selection was used to compare serum IL-8 levels between\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      -positive IBS patients and an equal number of randomly selected\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      -negative IBS patients. Clinical, biochemical, and demographic variables were analyzed in relation to infection status and subtype distribution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IBS was diagnosed in 197 out of 298 participants (66.1%), among whom 57 (28.9%) were positive for\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      . Subtype analysis revealed a predominance of subtype (ST) 3 (86%), followed by ST1 (14%). Serum IL-8 levels were significantly higher in\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      -infected IBS patients compared to non-infected controls (129.24\u2009\u00b1\u200956.28 vs. 26.28\u2009\u00b1\u20099.28 pg\/mL,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Multivariate analysis identified younger age, diarrhea, and spring presentation as independent predictors of\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      IBS is frequently associated with\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      infection, particularly with subtype ST3. Serum levels of IL-8 are higher in\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      -infected IBS patients as compared to uninfected ones. Statistical comparison between IL-8 levels in both subtype groups revealed no significant difference, despite the higher numerical values among the ST3 group. The potential aggravating effect of blastocystosis on IBS symptomatology and the relation between individual subtypes and the pro-inflammatory cytokine response require further mechanistic and longitudinal studies to clarify the causal relationship between\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      subtypes and IBS pathogenesis. In addition, local inflammatory markers should be used to study local immune modulation and identify molecular effectors implicated in the pathogenesis of\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      in IBS -infected patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13099-026-00887-5","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:37:45Z","timestamp":1792582665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Blastocystis subtype 3 with elevated IL-8\u2013mediated inflammation in patients with irritable bowel syndrome"],"prefix":"10.1186","volume":"18","author":[{"given":"Salwa M.","family":"Morsy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8092-6994","authenticated-orcid":false,"given":"Magda S. A.","family":"Abdeltawab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal M.","family":"Mahfoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Elkerdawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa S.","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira R.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"4","key":"887_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/gut.52.4.523","volume":"52","author":"KA Gwee","year":"2003","unstructured":"Gwee KA, Collins SM, Read NW. Increased rectal mucosal expression of interleukin 1B in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52(4):523\u20136. https:\/\/doi.org\/10.1136\/gut.52.4.523.","journal-title":"Gut"},{"key":"887_CR2","doi-asserted-by":"publisher","unstructured":"Aggeletopoulou I, Papantoniou K, Pastras P, Triantos C. Unraveling the pathophysiology of irritable bowel syndrome: Mechanisms and insights. Int J Mol Sci. 2025;26(21). https:\/\/doi.org\/10.3390\/ijms262110598. Article 10598.","DOI":"10.3390\/ijms262110598"},{"issue":"1","key":"887_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2982.2005.00627.x","volume":"17","author":"KA Gwee","year":"2005","unstructured":"Gwee KA. Irritable bowel syndrome in developing countries\u2014a disorder of civilization or colonization? Neurogastroenterol Motil. 2005;17(1):1\u20138. https:\/\/doi.org\/10.1111\/j.1365-2982.2005.00627.x.","journal-title":"Neurogastroenterol Motil"},{"key":"887_CR4","doi-asserted-by":"publisher","unstructured":"Lacy BE, Patel NK. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017;6(11). https:\/\/doi.org\/10.3390\/jcm6110099.","DOI":"10.3390\/jcm6110099"},{"issue":"29","key":"887_CR5","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.3748\/wjg.15.3591","volume":"15","author":"M Thabane","year":"2009","unstructured":"Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009;15(29):3591\u20136. https:\/\/doi.org\/10.3748\/wjg.15.3591.","journal-title":"World J Gastroenterol"},{"key":"887_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mehy.2018.04.006","volume":"116","author":"S Cifre","year":"2018","unstructured":"Cifre S, Gozalbo M, Ortiz V, Soriano JM, Merino JF, Trelis M. Blastocystis subtypes and their association with Irritable Bowel Syndrome. Med Hypotheses. 2018;116:4\u20139. https:\/\/doi.org\/10.1016\/j.mehy.2018.04.006.","journal-title":"Med Hypotheses"},{"issue":"1","key":"887_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5152\/tjg.2018.17642","volume":"30","author":"M K\u00f6k","year":"2019","unstructured":"K\u00f6k M, \u00c7ekin Y, \u00c7ekin AH, Uyar S, Harmandar F, \u015eahint\u00fcrk Y. The role of Blastocystis hominis in the activation of ulcerative colitis. Turkish J Gastroenterol. 2019;30(1):40\u20134. https:\/\/doi.org\/10.5152\/tjg.2018.17642.","journal-title":"Turkish J Gastroenterol"},{"issue":"6","key":"887_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00436-007-0671-1","volume":"101","author":"TC Tan","year":"2007","unstructured":"Tan TC, Suresh KG. Evidence of plasmotomy in B. hominis. Parasitol Res. 2007;101(6):1521\u20135. https:\/\/doi.org\/10.1007\/s00436-007-0671-1.","journal-title":"Parasitol Res"},{"issue":"1","key":"887_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00436-005-0003-0","volume":"98","author":"TK Graczyk","year":"2005","unstructured":"Graczyk TK, Shiff CK. The association of B. hominis and Endolimax nana with diarrheal stools in Zambian school-age children. Parasitol Res. 2005;98(1):38\u201343. https:\/\/doi.org\/10.1007\/s00436-005-0003-0.","journal-title":"Parasitol Res"},{"key":"887_CR10","doi-asserted-by":"publisher","unstructured":"Boorom KF, Smith H, Nimri L, Viscogliosi E, Spanakos G, Parkar U, Li LH, Zhou XN, Ok UZ, Leelayoova S, Jones MS. Oh my aching gut: Irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasites Vectors. 2008;1., Article 40. https:\/\/doi.org\/10.1186\/1756-3305-1-40.","DOI":"10.1186\/1756-3305-1-40"},{"key":"887_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1186\/s12879-026-13047-6","volume":"26","author":"NM Amin","year":"2026","unstructured":"Amin NM, Ismail AR, Aal A, S. M., et al. Association of Blastocystis species subtypes 3 and 4 with intestinal inflammation and response to metronidazole in symptomatic patients. BMC Infect Dis. 2026;26:744. https:\/\/doi.org\/10.1186\/s12879-026-13047-6.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"887_CR12","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1128\/iai.02279-14","volume":"82","author":"MX Lim","year":"2014","unstructured":"Lim MX, Png CW, Tay CY, Teo JD, Jiao H, Lehming N, Tan KSW, Zhang J. Differential regulation of proinflammatory cytokine expression by mitogen-activated protein kinases in macrophages in response to intestinal parasite infection. Infect Immun. 2014;82(11):4789\u2013801. https:\/\/doi.org\/10.1128\/iai.02279-14.","journal-title":"Infect Immun"},{"key":"887_CR13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.parint.2016.05.007","volume":"65","author":"SSR Ajjampur","year":"2016","unstructured":"Ajjampur SSR, Tan KSW. Pathogenic mechanisms in Blastocystis spp. \u2013 interpreting results from in vitro and in vivo studies. Parasitol Int. 2016;65:772\u20139. https:\/\/doi.org\/10.1016\/j.parint.2016.05.007. (6 Pt B).","journal-title":"Parasitol Int"},{"key":"887_CR14","doi-asserted-by":"publisher","unstructured":"Yason JA, Liang YR, Png CW, Zhang Y, Tan KSW. Interactions between a pathogenic Blastocystis subtype and gut microbiota: In vitro and in vivo studies. Microbiome. 2019;7., Article 30. https:\/\/doi.org\/10.1186\/s40168-019-0644-3.","DOI":"10.1186\/s40168-019-0644-3"},{"key":"887_CR15","doi-asserted-by":"publisher","first-page":"157013","DOI":"10.1016\/j.cyto.2025.157013","volume":"195","author":"MSA Abdeltawab","year":"2025","unstructured":"Abdeltawab MSA, Abdel Aal SM, Ali SM, Zaki KYW, El-Din S, S., Amin NM. Anti-inflammatory effect of probiotics in patients with Blastocystis spp. infection. Cytokine. 2025;195:157013. https:\/\/doi.org\/10.1016\/j.cyto.2025.157013.","journal-title":"Cytokine"},{"key":"887_CR16","doi-asserted-by":"publisher","unstructured":"Matovelle C, Tejedor MT, Monteagudo LV, Beltr\u00e1n A, Qu\u00edlez J. Prevalence and associated factors of Blastocystis sp. infection in patients with gastrointestinal symptoms in Spain: A case-control study. Trop Med Infect Disease. 2012;7(9). https:\/\/doi.org\/10.3390\/tropicalmed7090226. Article 226.","DOI":"10.3390\/tropicalmed7090226"},{"issue":"4","key":"887_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1017\/S0031182009991351","volume":"137","author":"S Chandramathi","year":"2010","unstructured":"Chandramathi S, Suresh K, Shuba S, Mahmood A, Kuppusamy UR. High levels of oxidative stress in rats infected with Blastocystis hominis. Parasitology. 2010;137(4):605\u201311. https:\/\/doi.org\/10.1017\/S0031182009991351.","journal-title":"Parasitology"},{"key":"887_CR18","doi-asserted-by":"publisher","unstructured":"Viloti\u0107 A, Nacka-Aleksi\u0107 M, Pirkovi\u0107 A, Boji\u0107-Trbojevi\u0107 \u017d, Dekanski D, Jovanovi\u0107 Krivoku\u0107a M. IL-6 and IL-8: An overview of their roles in healthy and pathological pregnancies. Int J Mol Sci. 2022;23(23). https:\/\/doi.org\/10.3390\/ijms232314574.","DOI":"10.3390\/ijms232314574"},{"issue":"9","key":"887_CR19","doi-asserted-by":"publisher","first-page":"Article1924","DOI":"10.3390\/microorganisms12091924","volume":"12","author":"S Tocci","year":"2024","unstructured":"Tocci S, Das S, Sayed IM. An update on Blastocystis: Possible mechanisms of Blastocystis-mediated colorectal cancer. Microorganisms. 2024;12(9):Article1924. https:\/\/doi.org\/10.3390\/microorganisms12091924.","journal-title":"Microorganisms"},{"issue":"1","key":"887_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.gastrohep.2021.02.022","volume":"45","author":"E de P\u00e9rez","year":"2022","unstructured":"de P\u00e9rez E, Quera R, Beltr\u00e1n CJ, Madrid AM, Nos P. Irritable bowel syndrome in inflammatory bowel disease. Synergy in alterations of the gut-brain axis? Gastroenterolog\u00eda y hepatolog\u00eda. 2022;45(1):66\u201376. https:\/\/doi.org\/10.1016\/j.gastrohep.2021.02.022.","journal-title":"Gastroenterolog\u00eda y hepatolog\u00eda"},{"issue":"4","key":"887_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4269\/ajtmh.2004.70.383","volume":"70","author":"J Yakoob","year":"2004","unstructured":"Yakoob J, Jafri W, Jafri N, Khan R, Islam M, Beg MA, Zaman V. Irritable bowel syndrome: In search of an etiology: Role of Blastocystis hominis. Am J Trop Med Hyg. 2004;70(4):383\u20135. https:\/\/doi.org\/10.4269\/ajtmh.2004.70.383.","journal-title":"Am J Trop Med Hyg"},{"key":"887_CR22","doi-asserted-by":"publisher","unstructured":"El Sharawy SM, Amer IF, Elkadeem MZ. Irritable bowel syndrome in Egyptian medical students, prevalence and associated factors: A cross-sectional study. Pan Afr Med J. 2022;41., Article 311. https:\/\/doi.org\/10.11604\/pamj.2022.41.311.28228.","DOI":"10.11604\/pamj.2022.41.311.28228"},{"key":"887_CR23","unstructured":"Centers for Disease Control and Prevention (CDC). Laboratory identification of parasites of public health concern. CDC DPDx; 2016. https:\/\/www.cdc.gov\/dpdx\/diagnosticprocedures."},{"issue":"3","key":"887_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.12691\/ijcd-6-3-4","volume":"6","author":"NK Tolipova","year":"2018","unstructured":"Tolipova NK, Azimova SB, Ataeva DR. Optimization of diagnosis and treatment of lactose intolerance in infants. Int J Celiac Disease. 2018;6(3):64\u20137. https:\/\/doi.org\/10.12691\/ijcd-6-3-4.","journal-title":"Int J Celiac Disease"},{"issue":"12","key":"887_CR25","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00436-016-5231-9","volume":"115","author":"A Seyer","year":"2016","unstructured":"Seyer A, Karasartova D, Ruh E, Gureser AS, Imir T, Taylan Ozkan A. Is dried stool spots on filter paper method (DSSFP) more sensitive and effective for detecting Blastocystis spp. and their subtypes by PCR and sequencing? Parasitol Res. 2016;115(12):4449\u201355. https:\/\/doi.org\/10.1007\/s00436-016-5231-9.","journal-title":"Parasitol Res"},{"issue":"1","key":"887_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00436-003-1004-5","volume":"92","author":"H Yoshikawa","year":"2004","unstructured":"Yoshikawa H, Wu Z, Kimata I, Iseki M, Ali IKMD, Hossain MB. Polymerase chain reaction-based genotype classification among human Blastocystis hominis population isolated from different countries. Parasitol Res. 2004;92(1):22\u20139. https:\/\/doi.org\/10.1007\/s00436-003-1004-5.","journal-title":"Parasitol Res"},{"issue":"8","key":"887_CR27","first-page":"391","volume":"44","author":"YH Chan","year":"2003","unstructured":"Chan YH. Biostatistics 102: Quantitative data \u2013 Parametric & non-parametric tests. Singapore Med J. 2003a;44(8):391\u20136.","journal-title":"Singapore Med J"},{"issue":"10","key":"887_CR28","first-page":"498","volume":"44","author":"YH Chan","year":"2003","unstructured":"Chan YH. Biostatistics 103: Qualitative data \u2013 Tests of independence. Singapore Med J. 2003b;44(10):498\u2013503.","journal-title":"Singapore Med J"},{"issue":"4","key":"887_CR29","first-page":"149","volume":"45","author":"YH Chan","year":"2004","unstructured":"Chan YH. Biostatistics 202: Logistic regression analysis. Singapore Med J. 2004;45(4):149\u201353.","journal-title":"Singapore Med J"},{"issue":"11","key":"887_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrgastro.2014.127","volume":"11","author":"R Sood","year":"2014","unstructured":"Sood R, Law G, Ford A. Diagnosis of IBS: Symptoms, symptom-based criteria, biomarkers or \u2018psychomarkers\u2019? Nat Reviews Gastroenterol Hepatol. 2014;11(11):683\u201391. https:\/\/doi.org\/10.1038\/nrgastro.2014.127.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"12","key":"887_CR31","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1097\/MEG.0000000000002994","volume":"37","author":"TB Arif","year":"2025","unstructured":"Arif TB, Ali SH, Bhojwani KD, Sadiq M, Siddiqui AA, Ur-Rahman A, Khan MZ, Hasan F, Shahzil M. Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: A meta-analysis. Eur J Gastroenterol Hepatol. 2025;37(12):1314\u201325. https:\/\/doi.org\/10.1097\/MEG.0000000000002994.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"887_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.21608\/ejom.2020.109590","volume":"44","author":"ZA Kasemy","year":"2020","unstructured":"Kasemy ZA, Sakr AA, Shebiny E, Elbasyouny EM, H. A., Dalatony E, M. M. Psychological status and irritable bowel syndrome among healthcare workers. Egypt J Occup Med. 2020;44(2):605\u201320. https:\/\/doi.org\/10.21608\/ejom.2020.109590.","journal-title":"Egypt J Occup Med"},{"issue":"3","key":"887_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.21608\/ejom.2023.195124.1305","volume":"47","author":"AA Abdel Latif","year":"2023","unstructured":"Abdel Latif AA, Sharif AF, Ata MB, Kasemy ZA. Prevalence and risk factors of irritable bowel syndrome among general secondary school teachers. Egypt J Occup Med. 2023;47(3):49\u201366. https:\/\/doi.org\/10.21608\/ejom.2023.195124.1305.","journal-title":"Egypt J Occup Med"},{"key":"887_CR34","doi-asserted-by":"publisher","unstructured":"Mostafa I, Hasan SMT, Gazi MA, et al. Alteration of stool pH and its association with biomarkers of gut enteropathy among slum-dwelling women of reproductive age in Bangladesh. BMC Womens Health. 2023;23., Article 661. https:\/\/doi.org\/10.1186\/s12905-023-02758-6.","DOI":"10.1186\/s12905-023-02758-6"},{"key":"887_CR35","doi-asserted-by":"publisher","first-page":"Article1192316","DOI":"10.3389\/frmbi.2023.1192316","volume":"2factory","author":"R Yamamura","year":"2023","unstructured":"Yamamura R, Inoue KY, Nishino K, Yamasaki S. Intestinal and fecal pH in human health. Front Microbiomes. 2023;2factory:Article1192316. https:\/\/doi.org\/10.3389\/frmbi.2023.1192316.","journal-title":"Front Microbiomes"},{"issue":"2","key":"887_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5056\/jnm.2014.20.2.228","volume":"20","author":"M Goebel-Stengel","year":"2014","unstructured":"Goebel-Stengel M, Stengel A, Schmidtmann M, Voort IV, Kobelt P, M\u00f6nnikes H. Unclear abdominal discomfort: Pivotal role of carbohydrate malabsorption. J Neurogastroenterol Motil. 2014;20(2):228\u201335. https:\/\/doi.org\/10.5056\/jnm.2014.20.2.228.","journal-title":"J Neurogastroenterol Motil"},{"issue":"8","key":"887_CR37","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3945\/jn.112.159285","volume":"142","author":"HM Staudacher","year":"2012","unstructured":"Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012;142(8):1510\u20138. https:\/\/doi.org\/10.3945\/jn.112.159285.","journal-title":"J Nutr"},{"issue":"3","key":"887_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.21608\/puj.2023.239538.1224","volume":"16","author":"EA El Saftawy","year":"2023","unstructured":"El Saftawy EA, Ghallab MMI, Haydara T, Ibrahim A, Atta SA, Allah G, Kamel RA, M. N., Morsy SM. Assessment of host biochemical factors and microbiota interactions and pathogenicity of Blastocystis hominis genotypes: A cross-sectional study. Parasitologists United J. 2023;16(3):183\u201391. https:\/\/doi.org\/10.21608\/puj.2023.239538.1224.","journal-title":"Parasitologists United J"},{"issue":"4","key":"887_CR39","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3748\/wjg.v22.i4.1331","volume":"22","author":"JR Thompson","year":"2016","unstructured":"Thompson JR. Is irritable bowel syndrome an infectious disease? World J Gastroenterol. 2016;22(4):1331\u20134. https:\/\/doi.org\/10.3748\/wjg.v22.i4.1331.","journal-title":"World J Gastroenterol"},{"key":"887_CR40","doi-asserted-by":"publisher","unstructured":"Olyaiee A, Sadeghi A, Yadegar A, Mirsamadi ES, Mirjalali H. Gut microbiota shifting in irritable bowel syndrome: The mysterious role of Blastocystis sp. Front Med (Lausanne). 2022;9., Article 890127. https:\/\/doi.org\/10.3389\/fmed.2022.890127.","DOI":"10.3389\/fmed.2022.890127"},{"issue":"7","key":"887_CR41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1017\/S003118201300224X","volume":"141","author":"J Yakoob","year":"2014","unstructured":"Yakoob J, Abbas Z, Usman MW, Sultana A, Islam M, Awan S. Cytokine changes in colonic mucosa associated with Blastocystis spp. subtypes 1 and 3 in diarrhoea-predominant irritable bowel syndrome. Parasitology. 2014;141(7):957\u201364. https:\/\/doi.org\/10.1017\/S003118201300224X.","journal-title":"Parasitology"},{"issue":"3","key":"887_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/0049475519837112","volume":"49","author":"AI Salem","year":"2019","unstructured":"Salem AI, El-Taweel HA, Madkour MA, El-Latif A, N. F., Abd-Elrazeq ES. Irritable bowel syndrome in Egyptian patients: Plausible risk factors and association with intestinal protozoa. Trop Doct. 2019;49(3):184\u20138. https:\/\/doi.org\/10.1177\/0049475519837112.","journal-title":"Trop Doct"},{"issue":"3","key":"887_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cgh.2014.07.065","volume":"13","author":"LR Krogsgaard","year":"2015","unstructured":"Krogsgaard LR, Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P. The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: A population-based case-control study. Clin Gastroenterol Hepatol. 2015;13(3):507\u2013e5132. https:\/\/doi.org\/10.1016\/j.cgh.2014.07.065.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"887_CR44","doi-asserted-by":"publisher","unstructured":"Beiromvand M, Hashemi SJ, Arjmand R, Sadjadei N, Hardanipasand L. Comparative prevalence of Blastocystis in patients with the irritable bowel syndrome and healthy individuals: A case control study. Jundishapur J Microbiol. 2017;10(6). https:\/\/doi.org\/10.5812\/jjm.13572. Article e13572.","DOI":"10.5812\/jjm.13572"},{"issue":"2","key":"887_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00436-009-1693-5","volume":"106","author":"L Souppart","year":"2010","unstructured":"Souppart L, Moussa H, Cian A, Sanciu G, Poirier P, El Alaoui H, Delbac F, Boorom K, Delhaes L, Dei-Cas E, Viscogliosi E. Subtype analysis of Blastocystis isolates from symptomatic patients in Egypt. Parasitol Res. 2010;106(2):505\u201311. https:\/\/doi.org\/10.1007\/s00436-009-1693-5.","journal-title":"Parasitol Res"},{"issue":"1","key":"887_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00436-017-5679-4","volume":"117","author":"AA El-Badry","year":"2018","unstructured":"El-Badry AA, Wahab AE, Hamdy WM, D. A., Aboud A. Blastocystis subtypes isolated from irritable bowel syndrome patients and co-infection with Helicobacter pylori. Parasitol Res. 2018;117(1):127\u201337. https:\/\/doi.org\/10.1007\/s00436-017-5679-4.","journal-title":"Parasitol Res"},{"key":"887_CR47","doi-asserted-by":"publisher","unstructured":"Ahmed SA, El-Mahallawy HS, Mohamed SF, Angelici MC, Hasapis K, Saber T, Karanis P. Subtypes and phylogenetic analysis of Blastocystis sp. isolates from West Ismailia, Egypt. Sci Rep. 2022;12(1). https:\/\/doi.org\/10.1038\/s41598-022-23360-0.","DOI":"10.1038\/s41598-022-23360-0"},{"issue":"9","key":"887_CR48","doi-asserted-by":"publisher","first-page":"8837","DOI":"10.1007\/s11033-012-1745-2","volume":"39","author":"M Romero-Valdovinos","year":"2012","unstructured":"Romero-Valdovinos M, Gudi\u00f1o-Ram\u00edrez A, Reyes-Gordillo J, et al. Interleukin-8 and \u2013\u200910 gene polymorphisms in irritable bowel syndrome. Mol Biol Rep. 2012;39(9):8837\u201343. https:\/\/doi.org\/10.1007\/s11033-012-1745-2.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"887_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12328-021-01555-8","volume":"15","author":"S Kumar","year":"2022","unstructured":"Kumar S, Singh P, Kumar A. Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines. Clin J Gastroenterol. 2022;15(1):1\u201310. https:\/\/doi.org\/10.1007\/s12328-021-01555-8.","journal-title":"Clin J Gastroenterol"},{"issue":"7","key":"887_CR50","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/nmo.12358","volume":"26","author":"M Bashashati","year":"2014","unstructured":"Bashashati M, Rezaei N, Shafieyoun A, McKernan DP, Chang L, \u00d6hman L, Quigley EM, Schmulson M, Sharkey KA, Simr\u00e9n M. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2014;26(7):1036\u201348. https:\/\/doi.org\/10.1111\/nmo.12358. Epub 2014 May 5. PMID: 24796536.","journal-title":"Neurogastroenterol Motil"},{"issue":"8","key":"887_CR51","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.3390\/jcm9082353","volume":"9","author":"GP Caviglia","year":"2020","unstructured":"Caviglia GP, Tucci A, Pellicano R, Fagoonee S, Rosso C, Abate ML, Olivero A, Armandi A, Vanni E, Saracco GM, et al. Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report. J Clin Med. 2020;9(8):2353. https:\/\/doi.org\/10.3390\/jcm9082353.","journal-title":"J Clin Med"},{"key":"887_CR52","doi-asserted-by":"publisher","unstructured":"Pawelec-P\u0119ciak O, \u0141anocha-Arendarczyk N, Grzeszczak K, Kosik-Bogacka D. The role of Blastocystis spp. in the etiology of gastrointestinal and autoimmune diseases. Pathogens. 2025;14(4). https:\/\/doi.org\/10.3390\/pathogens14040313.","DOI":"10.3390\/pathogens14040313"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-026-00887-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-026-00887-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-026-00887-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:02:15Z","timestamp":1792731735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-026-00887-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1186\/s13099-026-00887-5","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the ethical principles of the Declaration of Helsinki (2013) including the acquisition of written informed consent. Ethical approval was obtained from the Ethical Committee of the Faculty of Medicine, Kafr El-Sheikh University (Approval No. KFSIRB200-921).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"82"}}